Table 2. The morbidity rate of S. sclerotiorum infection at early stage.
Wild type | BnMAM1 | BnCYP83A1 | BnUGT74B1 | ||||
---|---|---|---|---|---|---|---|
WT | OE-M-1 | OE-M-2 | OE-C-1 | OE-C-42 | OE-U-1 | OE-U-2 | |
16 hpi | 46 | 47 | 37 | 37 | 42 | 3 | 4 |
Total | 49 | 51 | 40 | 39 | 46 | 41 | 43 |
Ratio | 93.88% | 92.16% | 92.50% | 94.87% | 91.30% | 7.32% | 9.30% |
The ratio of the number of inoculation sites showing necrosis to the total number of inoculation sites was expressed as early stage morbidity. The lines OE-M-1 and OE-M1-2 are transgenic for BnMAM1. The lines OE-C-1 and OE-C-2 are transgenic for BnCYP83A1. The lines OE-U-1 and OE-U-2 are transgenic for BnUGT74B1. WT, untransformed wild-type control.